Embedded Files
Now Accepting New Patients Call 516-808-0888 to get started
The First and Only FDA Authorized Digital Treatment for Depression Symptoms
The First and Only FDA Authorized Digital Treatment for Depression Symptoms
ManuMind Interventional Psychiatry offers Rejoyn, a prescription treatment for adults age 22+ with major depressive disorder (MDD) on antidepressant medication. Like physical therapy for your brain, over the course of 6 weeks, Rejoyn treats depression symptoms with proven brain-training exercises and short skills-based therapy lessons.
Brain-training exercises:
For some people with depression, the feeling part of the brain (the amygdala) and the thinking part of the brain (the prefrontal cortex) have trouble communicating.
When these parts aren’t communicating properly with one another, the brain struggles to process emotions. As negative emotions become more and more powerful, it can make people feel like they're spiraling.
The brain-training exercise in Rejoyn is designed to activate these parts of the brain at the same time.
How does Rejoyn work?
How does Rejoyn work?
The brain-training exercise in Rejoyn involves identifying and remembering emotions on a series of faces. When you identify the emotion, you activate the amygdala. When you remember the emotion of the previous face, you activate the prefrontal cortex. This may help to strengthen the connection between these brain regions so they’re able to communicate better. This may also help the brain process emotions and improve depression symptoms.
Rejoyn is intended for adults age 22+ who:
Rejoyn is intended for adults age 22+ who:
Have a diagnosis of major depressive disorder, also known as depression
Are currently managing their depression with an antidepressant medication and want to do more
Have access to a smartphone
Want an alternative option that complements their current depression treatment
This 6-week program is designed to:
This 6-week program is designed to:
REBUILD
REBUILD
neural connections
REWORK
REWORK
how your brain processes emotions
REDUCE
REDUCE
depression symptoms
INDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.
INDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.
SAFETY INFORMATION: Rejoyn is not intended to be used as a standalone treatment. Rejoyn does not replace your current medication, including medication for treatment of MDD. You should continue your current treatment as directed by your healthcare provider.
Please see Patient Instructions for Use at Rejoyn.com/IFU
Page updated
Report abuse